Compare Citatah Tbk. (CTTH) vs Cipta Sarana Medika Tbk. (DKHH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citatah Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Citatah Tbk. trades at Rp109 (market cap 134.16B), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B). The key difference: Cipta Sarana Medika Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| CTTH | DKHH | |
|---|---|---|
Market Cap | 134.16B | 160.67B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citatah Tbk.
Citatah was the first private company to develop Indonesia’s marble resources, and has been involved in the extraction and processing of marble for twenty five years. Established in 1974, the company began mining began mining beige marble from its quarry near Bandung, and subsequently achieved a dominant market position for its material in Indonesia. In January 1996, the company acquired a 90% shareholding in PT Quarindah Ekamaju Marmer, a marble company with quarries and a modern processing plant in Singkep, South Sulawesi. Soon after, Citatah acquired a license to mine an additional quarry at Pingkep, which increased the company’s potential raw material output to 60,000 cubic meters a year. In 1998, Citatah opened its Special Projects Centre at Karawang, East of Jakarta. This processing facility comprises a marble and granite slab cutting and polishing factory alongside a design and fabrication factory, which houses a variety of specialist cutting, shaping and finishing machinery. The special projects center is considered to be one of the most modern and complete stone fabrication factories in the world. In 1999, Citatah began excavation at a 50 hectare quarry site in West Timur. This new quarry produces a unique and attractive beige marble which will become the company’s principal export product for the new millennium. Work has already begun on the necessary infrastructure to fully develop the quarry site. An international sales network of agents and representatives supports Citatah’s production, and a majority owned sales subsidiary, UGMC Inc., in California, USA. In 1999, three quarters of the company’s production was exported, mainly to markets in the Asia Pacific region and the US, an overseas revenues accounted for over 90% of Total Sales, and in 2000, 75% of Total Sales.
Read more on CTTH →About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
